BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16441633)

  • 1. Intravenous cidofovir treatment for recalcitrant warts in the setting of a patient with myelodysplastic syndrome.
    Gröne D; Treudler R; de Villiers EM; Husak R; Orfanos CE; Zouboulis ChC
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):202-5. PubMed ID: 16441633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of florid cutaneous warts with intravenous cidofovir in an 11-year-old girl.
    Cusack C; Fitzgerald D; Clayton TM; Irvine AD
    Pediatr Dermatol; 2008; 25(3):387-9. PubMed ID: 18577053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantial effect of topical cidofovir 1% on recalcitrant warts in a renal-transplanted adolescent: a case report.
    Kralund HH; Broesby-Olsen S; Bistrup C; Lorentzen HF
    Transplantation; 2011 Apr; 91(7):e52-4. PubMed ID: 21436652
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV.
    Hivnor C; Shepard JW; Shapiro MS; Vittorio CC
    Arch Dermatol; 2004 Jan; 140(1):13-4. PubMed ID: 14732654
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of periungual warts with topical cidofovir.
    Padilla España L; Del Boz J; Fernández Morano T; Arenas-Villafranca J; de Troya M
    Dermatol Ther; 2014; 27(6):337-42. PubMed ID: 25081902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature.
    Cha S; Johnston L; Natkunam Y; Brown J
    Transpl Infect Dis; 2005; 7(3-4):158-61. PubMed ID: 16390407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous cidofovir for resistant cutaneous warts in a patient with psoriasis treated with monoclonal antibodies.
    McAleer MA; Bourke J
    Clin Exp Dermatol; 2011 Aug; 36(6):638-40. PubMed ID: 21771010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts.
    Broganelli P; Chiaretta A; Fragnelli B; Bernengo MG
    Dermatol Ther; 2012; 25(5):468-71. PubMed ID: 23046027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional cidofovir in the treatment of cutaneous warts in a renal transplant patient.
    Blouin MM; Cloutier R; Noël R
    J Cutan Med Surg; 2012; 16(6):462-4. PubMed ID: 23149209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical cidofovir for plantar warts.
    Padilla España L; Del Boz J; Fernández Morano T; Arenas Villafranca J; de Troya Martín M
    Dermatol Ther; 2014; 27(2):89-93. PubMed ID: 24433270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical cidofovir as a treatment for plantar warts].
    Troncoso Mariño A; Cuiña González JR; Inaraja Bobo MT; Allegue Rodríguez F
    Farm Hosp; 2010; 34(1):48-9. PubMed ID: 20144824
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin's lymphoma.
    De Socio GV; Simonetti S; Rosignoli D; Minga P; Tomassini GM; Baldelli F
    Int J STD AIDS; 2008 Oct; 19(10):715-6. PubMed ID: 18824628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical cidofovir for refractory verrucae in children.
    Gupta M; Bayliss SJ; Berk DR
    Pediatr Dermatol; 2013; 30(1):131-4. PubMed ID: 23013353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical cidofovir for viral warts in children.
    Fernández-Morano T; del Boz J; González-Carrascosa M; Tortajada B; de Troya M
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1487-9. PubMed ID: 21261749
    [No Abstract]   [Full Text] [Related]  

  • 15. Local treatment of HPV-induced skin lesions by Cidofovir.
    Stragier I; Snoeck R; De Clercq E; Van Den Oord JJ; Van Ranst M; De Greef H
    J Med Virol; 2002 Jun; 67(2):241-5. PubMed ID: 11992585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional cidofovir for the treatment of a plantar wart.
    Moore E; Kovarik C
    J Am Acad Dermatol; 2015 Jul; 73(1):e23-4. PubMed ID: 26089066
    [No Abstract]   [Full Text] [Related]  

  • 17. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients.
    Bonatti H; Aigner F; De Clercq E; Boesmueller C; Widschwendner A; Larcher C; Margreiter R; Schneeberger S
    Transpl Int; 2007 Mar; 20(3):238-46. PubMed ID: 17291217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of refractory cutaneous warts using topical 3% cidofovir in a child after heart transplant.
    Cleary A; Watson R; McMahon CJ
    J Heart Lung Transplant; 2014 Sep; 33(9):971-2. PubMed ID: 24726426
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intralesional cidofovir in human papilomavirus infection in interdigital spaces].
    Pi Sala N; Figueras Suriol A; Ramió Montero E
    Farm Hosp; 2017 Jan; 41(n01):132-133. PubMed ID: 28045657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.